{"contentid": 488192, "importid": NaN, "name": "Germany\u00e2\u0080\u0099s STADA Arz plans to accelerate expansion in Russian", "introduction": "German drugmaker STADA Arzneimittel (SAZ: Xetra) plans to accelerate its expansion in the Russian pharmaceutical market in the coming years, Stefan Eder, executive vice president of STADA in Russia and the CIS, said in an interview with the Russian Kommersant business paper.", "content": "<p>German drugmaker STADA Arzneimittel (SAZ: Xetra) plans to accelerate its expansion in the Russian pharmaceutical market in the coming years, Stefan Eder, executive vice president of STADA in Russia and the CIS, said in an interview with the Russian Kommersant business paper.&nbsp;</p>\n<p>According to Mr Eder, over the past 15 years, STADA has invested over $1 billion in the Russian and CIS market, including a record $660 million on the purchase of Takeda's portfolio in 2020.</p>\n<p>Mr Eder said in the next three years, the company plans to invest 13 million euros ($15.3 million) to increase the capacities of its local production sites of Nizhpharm and Hemofarm.&nbsp;</p>\n<p>At present, the level of localization of STADA in Russia is estimated at 70%, which is one of the highest figures among the other global drugmakers operating in the local market.&nbsp;</p>\n<p>As Mr Eder has also noted, currently the company continues the transfer of technologies to Nizhpharm from its production sites in Serbia and the UK for the production of soft dosage forms.&nbsp;</p>\n<p>The drugs transferred from Serbia will be produced at a volume of more than 1 million units per year and will be delivered mainly to the Balkans and the CIS countries. The drugs transferred from the UK will be produced at almost 2 million units per year and will be supplied to the markets of seven countries, including the UK, UAE, Yemen.</p>\n<p>Next year, the company will complete the transfer of the technology for the production of drugs that are now manufactured at Takeda factories in Ireland and Germany to the Russian Hemofarm. That will be six drugs with a production volume of up to 13 million packs per year.</p>\n<p>Last year became successful for the company in Russia and the CIS region, as the growth of sales in the segment of original drugs amounted to 99%, while in the case of generics, by 12% compared to 2019.</p>", "date": "2021-03-30 10:20:00", "meta_title": "Germany\u00e2\u0080\u0099s STADA Arz plans to accelerate expansion in Russian", "meta_keywords": "STADA Arzneimittel, Expansion, Russia, Investment, Hemofarm, Nizhpharm", "meta_description": "Germany\u00e2\u0080\u0099s STADA Arz plans to accelerate expansion in Russian", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-30 10:18:52", "updated": "2021-03-30 10:27:14", "access": NaN, "url": "https://www.thepharmaletter.com/article/germany-s-stada-arz-plans-to-accelerate-expansion-in-russian", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "stada-location-big.jpg", "image2id": "stada-location-small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Generics", "therapy area_tag": NaN, "topic_tag": "Focus On, Production, Russian market", "geography_tag": "Germany, Russia", "company_tag": "Hemofarm, STADA Arzneimittel", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-30 10:20:00"}